Cerebrolysin — Research Evidence & Community Data
Also known as: neuropeptide preparation, FPF-1070
Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.
What Is Cerebrolysin?
Cerebrolysin is a peptide preparation derived from porcine brain tissue, marketed in several countries for stroke, dementia, and traumatic brain injury, but not approved by the FDA in the United States. Human clinical trials exist with mixed results, and meta-analyses have reached cautious or inconclusive conclusions for several indications. It is administered by injection in the countries where it is available.
Is Cerebrolysin FDA Approved?
Cerebrolysin is not fda approved. It is treated as a research compound in the United States with no approved human clinical applications.
What Does the Research Show?
As of 2026, there are 8 human randomized controlled trials with a combined 3,000 subjects, and 25 animal model studies. Numerous human trials exist (stroke, dementia, TBI) but meta-analyses are cautious or inconclusive. Not FDA-approved.
No linked evidence entries yet.
What Do Community Logs Show?
No community logs include Cerebrolysin yet. Browse community logs →
How Is Cerebrolysin Used in Research?
Mechanism of action. Proposed neurotrophic and neuroprotective activity from a mixture of low-molecular-weight peptides and amino acids.
Half-life. Administered as a multi-component preparation; pharmacokinetics are complex.
Storage. Approved abroad as a finished injectable; follow regional labeling.
Reconstitution. Finished preparation where available; reconstitution math is not applicable. See the reconstitution calculator — a math tool only, not dosing guidance.
What Does Cerebrolysin's Evidence Tier Mean?
Cerebrolysin is rated Tier 2 · Observational. Supported by human observational or clinical reports. Evidence tiers are a shorthand for how strong the human data is — Tier 1 reflects human randomized controlled trials, while lower tiers rest on observational, animal, or theoretical evidence. A higher tier means more confidence that observed effects are real and caused by the compound rather than by chance or bias. For how to weigh each tier, see our guide to understanding peptide evidence tiers.
How Do You Evaluate Cerebrolysin Sourcing and Quality?
Because research-chemical Cerebrolysin is unregulated, sourcing quality varies widely between sellers. Before trusting any supplier, check its reputation and enforcement history in the ranked list of trusted peptide sellers, and look for a batch-specific certificate of analysis (COA) showing third-party HPLC or LC-MS purity testing. Purity claims without a named lab, a batch number, and a method are marketing, not data. If you are reconstituting lyophilized material, the reconstitution calculator handles the arithmetic — it is a math tool only and not dosing guidance.
Where to Buy Cerebrolysin: Trusted & Verified Sellers
Cerebrolysin is supplied by specialist research-chemical sellers rather than pharmacies, so where you buy it matters as much as what you buy. The sellers below have published moderator-approved third-party lab results for Cerebrolysin, ranked by overall reputation score. Always confirm a current batch-specific COA before purchasing.
No seller has published a lab result for Cerebrolysin yet. Browse the ranked directory of trusted peptide sellers and check each one's lab testing and enforcement record before buying.
PeptidesHub does not sell Cerebrolysin or facilitate transactions — this list is for research transparency only.
How Are Adverse Reactions to Cerebrolysin Reported?
Structured adverse-event reports help the whole community spot safety signals early. You can browse approved reports on the adverse events page or submit one yourself. For a serious or life-threatening reaction, seek medical care and report it to FDA MedWatch.
Frequently Asked Questions
Cerebrolysin is not fda approved. It is treated as a research compound in the United States.